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1. Introduction 
The antibiotic rifamycin and its various derivatives 
strongly inhibit procaryotic DNA dependent RNA 
polymerases [ 11. Presently it is believed that the anti- 
biotic complexes with free RNA polymerase molecules 
which then become unable to bind the initial nu- 
cleoside triphosphate thus preventing transcription 
[2-51. Studies with E. coli RNA polymerase revealed 
that both core (p’pol?) and holo enzyme (fl’& u) are 
inhibited by rifamycin derivatives [ 1 ] . Although the 
mechanism of action of rifamycin has been the sub- 
ject of many studies, there remained open questions. 
We were interested in the problem, whether certain 
protein subunits, like u or w are displaced from holo 
enzyme upon binding of rifamycin. The experimental 
approach which we employed, was to investigate the 
binding of RNA polymerase from E. coli to matrix 
bound rifamycin [6]. 
2. Materials and methods 
E. coli’RNA polymerase holo enzyme was isolated 
according to literature [7,8] . 3- (2-aminoethyl) -thio- 
rifamycin SV was synthesized following a published 
F’ig.1. 3- (2-aminoethyl) -thiorifamycin-Sepharose. 
North-Holland Publishing Company - Amsterdam 
procedure [9]. SDS gel electrophoresis was performed 
according to [lo] . E. coli cells, strain MRE 600, were 
purchased from Fa. E. Merck. Rifamycin-Sepharose: 
10 ml Sepharose 4B (Pharmacia) were activated with 
CNBr as described [ 111. 3- (2-aminoethyl) -thio-rifa- 
mycin (10 mg) was dissolved in a mixture of 7 ml DMF 
and 2.5 ml 0.065 M phosphate buffer pH 7. This solu- 
tion was added to the activated Sepharose and the 
suspension stirred over night at 4°C. The rifamycin- 
Sepharose was extensively washed with a mixture of 
H20-DMSO (3: 1, v/v). From the absorbance (450 nm) 
of the combined filtrates a yield of 95% was estimated 
for the coupling reaction. 
3. Results and discussion 
A procedure is described in the literature which 
allows the derivatization of rifamycin SV to 3(2-ami- 
noethyl)-thiorifamycin SV [9]. This derivative, bearing 
a reactive primary amino group, covalently reacted 
with Sepharose, activated by CNBr. Prolonged washing 
of rifamycin-Sepharose at 4°C did not remove appre- 
ciable amounts of rifamycin, as judged from attempts 
to inhibit RNA polymerase by these filtrates. A rather 
impure preparation of RNA polymerase holo enzyme, 
containing both u-subunit and w-protein component, 
was applied to a rifamycin-Sepharose column. A gradient 
of 0.1-4 M LiCl removed only traces of enzymes. Under 
denaturating conditions, using 6 M urea-mercap;o- 
ethanol, a protein fraction was eluted, which according 
to SDS gel electrophoresis contained the protein com- 
ponents of pure RNA polymerase holo enzyme: p’parzo 
(fig. 2a,b). The application of large amounts of proteins 
of the urea fraction to SDS gels did not reveal traces 
of the protein component o. 
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Fig.2 a) RNA polymerase holo enzyme (2 mgf in 2 ml 0.1 M NaCl, 10 mM Tris pH 7.9 was applied to a 1 ml rifamycin-Sepharose 
column at 4’C. The column was washed with 5 ml 0.1 M NaCl, followed by a linear gradient of 0.1-4 M LiCl in 10 mM Tris pH 
7.9. Finally the Sepharose was eluted with 6 M urea, 2 mM mercaptoethanol. The enzymatic activity was measured in a standard 
assay [ 71. Appropriate fractions were dialysed against 10 mM Tris pH 7.9, concentrated by vacuum dialysis and subjected to SDS 
gel electrophoresis. (- ) enzymatic activity, (- ) absorbance at280 nm. b) SDS gels: 1, fraction 35-45; 2, RNA polyme- 
rase; 3,0.1 M NaCl fraction; 4-6;6 M urea fraction; 7, RNA polymerase. 
Employing an excess of rifamycin-Sepharose, it 
was observed that a certain amount of RNA poly 
merase, varying from preparation to preparation, did 
not bind. This protein fraction, although displaying 
the correct subunit pattern in SDS gel electrophoresis 
of RNA polymerase holo enzyme, was enzymatically 
inactive. 
Sometimes preparations of RNA polymerase holo 
enzyme contain an additional protein component with 
mol. wt of approx. 110 000. Stetter et al. who 
termed this component ‘x’ assume that it might be 
identical with protein factor ‘i’ of Burgess et al. [ 131 
and the ‘inactive u’ of Niisslein et al. [ 141. An enzyme 
preparation containing ‘x’ was chromatographed on 
rifamycin-Sepharose. 
The column was washed with either 0.1 or 4 M 
NaCl, then proteins were eluted with 6 M urea. SDS 
gels of the respective urea fractions showed that the 
protein component ‘x’ was still present. Hence high 
ionic strength did not displace this protein component 
from holo enzyme bound to rifamycin-Sepharose 
(frg.3). 
The results can be summarized as follows: purified, 
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Fig.3. RNA polymerase, (0.5 mg), containing protein compo- 
nent ‘x’ was applied to a 1 ml rifamycin-Sepharose column. 
The column was washed with either 0.1 M NaCl or 4 M NaCl. 
Protein was eluted by 6 M urea, 2 mM mercaptoethanol. SDS 
gels of urea fractions: 3, treatment with 4 M NaCl; 2, treatment 
with 0.1 M NaCl; 1, RNA polymerase, unchromatographed. 
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native E. coli RNA polymerase strongly bound to to Professor G. Hartmann, who kindly informed us 
rifamycin-Sepharose, nzymatically inactive enzyme about his results on similar esearch objectives. This 
did not. RNA polymerase protein was eluted by 6 M work was supported by the Deutsche Forschungsge- 
urea. Subunit u, in contrast o protein component w, meinschaft . 
was not displaced by high ionic strength from holo enzy- 
me bound to rifamycin-Sepharose. A protein compo- 
nent ‘x’ of mol. wt 110 000, sometimes found in RNA 
polymerase preparations, was likewise not displaced 
by high ionic strength from holo enzyme. From this 
we conclude that the protein component ‘x’ is part of 
the native E. coli RNA polymerase. Its function 
remains to be elucidated. 
As shown by Zillig et al. [ 151 E. coli RNA polyme- 
rase can be dissociated by LiCl into-different complex- 
es of subunits. The dissociation of the enzyme seemed 
to start below 4 M LiCl. RNA polymerase holo enzyme 
bound to rifamycin-Sepharose, however, could not be 
removed by elution with a linear gradient of 0.1-4 M 
LiCI. From this observation we conclude that binding 
of rifamycin to RNA polymerase stabilizes the inter- 
actions between subunits. Attempts to use rifamycin- 
Sepharose for the isolation of RNA polymerase from 
crude extracts of bacteria re presently undertaken. 
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